Your session is about to expire
← Back to Search
Procedure
Goal-Directed CPR for Cardiac Arrest
N/A
Recruiting
Led By Sam Parnia, MD, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age <80 years
Age ≥18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 30
Awards & highlights
Study Summary
This trial will assess whether physiological feedback CPR can improve survival and neurological outcomes in adults who suffer in-hospital cardiac arrests, compared to non-physiological feedback CPR.
Who is the study for?
This trial is for adults aged 18-80 who experience a cardiac arrest inside NYU Tisch Hospital and require CPR for at least 5 minutes. It's not open to those with more than two acute organ failures, previous recent cardiac arrests, or certain brain conditions.Check my eligibility
What is being tested?
The study compares two types of CPR in a hospital setting: one using physiological feedback based on cerebral oxygen levels and another using non-physiological audiovisual cues to guide resuscitation efforts.See study design
What are the potential side effects?
Potential side effects are not explicitly listed but may include complications related to the quality of CPR such as varying degrees of neurological outcomes depending on the method used.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am younger than 80 years old.
Select...
I am 18 years old or older.
Select...
I have undergone CPR for 5 minutes or longer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 30
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 30
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rate of Return of Spontaneous Circulation (ROSC)
Secondary outcome measures
Cerebral Performance Category (CPC) Score
Change in mean ETCO2 during CPR as markers of the quality of resuscitation
Change in mean rSO2 during CPR as markers of the quality of resuscitation
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Physiological Feedback CPRExperimental Treatment1 Intervention
Group II: Non-Physiological (Audiovisual) Feedback CPRActive Control1 Intervention
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,369 Previous Clinical Trials
840,485 Total Patients Enrolled
9 Trials studying Ischemia
12,372 Patients Enrolled for Ischemia
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,837 Previous Clinical Trials
47,851,444 Total Patients Enrolled
49 Trials studying Ischemia
134,262 Patients Enrolled for Ischemia
Sam Parnia, MD, PhDPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
520 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am younger than 80 years old.I am between 18 and 80 years old.People who have had a heart attack outside of the hospital.I have had 3 or more sudden organ failures.You recently had a cardiac arrest while in the hospital.I have been treated with a heart-lung machine.I am 18 years old or older.Your bilirubin level is higher than 1.0 mg/dl, as measured by a special light test.I have had a recent brain injury, hemorrhage, or a frontal lobe tumor.I have undergone CPR for 5 minutes or longer.I have been diagnosed with increased pressure in my brain.I have had more than one heart attack in the hospital within the last 14 days.
Research Study Groups:
This trial has the following groups:- Group 1: Physiological Feedback CPR
- Group 2: Non-Physiological (Audiovisual) Feedback CPR
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are individuals aged under 65 years of age admissible to participate in this experiment?
"According to the clinical trial's participation requirements, adults aged between 18 - 80 are eligible to be included in this experiment."
Answered by AI
Is the trial accepting participants at this time?
"Affirmative, according to clinicaltrials.gov the listing for this trial has been updated on June 16th 2022 and is actively seeking participants. 150 patients are needed at one centre in order to proceed with the study."
Answered by AI
What is the total number of participants in this experimentation?
"Affirmative. The clinicaltrials.gov portal confirms that the trial, which commenced on February 11th 2022, is actively recruiting potential participants. 150 individuals are sought from a single location in order to complete the study's requirements."
Answered by AI
Are there any restrictions for participants in this medical trial?
"This study is currently recruiting 150 individuals affected by ischemia aged 18-80. To quality, one must have suffered an in-hospital cardiac arrest and had cardiopulmonary resuscitation lasting 5 minutes or longer."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger